The NIH Guidelines provides the IBC with the standards that guide containment and safe reserach practices for recombinant DNA research. The Recombinant DNA Program promotes scientific advancement and safety in the conduct of basic and clinical recombinant DNA research.

The NIH Office of Biotechnolocy Activities (OBA) promotes science, safety, and ethics in biotechnology through advancement of knowledge, enhancement of public understanding, and development of sound public policies. OBA accomplishes its mission through analysis, deliberation, and communication of scientific, medical, ethical, legal, and social issues.

The Dual Use Research Program is a focal point for the development of policies addressing life sciences research that yield information or technologies with the potential to be misused to threaten publich health or national security.

 The Boston Public Health Commission Biological Laboratory Regulations govern labs using biological agents and recombinant DNA in the city of Boston.

The Federal Select Agent Program is jointly comprised of the Centers for Disease Control and Prevention/Division of Select Agents and Toxins and the Animal and Plant Health Inspection Services/Agricultural Select Agent Program. The Federal Select Agent Program oversees the possession, use and transfer of biological select agents and toxins, which have the potential to pose a severe threat to public, animal or plant health or to animal or plant products.

APHIS issues permits for the import, transit and release of regulated animals, animal products, veterinary biologics, plants, plant products, pests, organisms, soil, and genetically engineered organisms.

  •  Final Rule on Possession, Use and Transfer of Select Agents and Toxins – CDC & USDA

Provides more specific information from the CDC and USDA on Select Agent Regulations.

Provides more resources on biosafety guidelines.